155 related articles for article (PubMed ID: 9826495)
1. DNA-induced conformational changes are the basis for cooperative dimerization by the DNA binding domain of the retinoid X receptor.
Holmbeck SM; Dyson HJ; Wright PE
J Mol Biol; 1998 Dec; 284(3):533-9. PubMed ID: 9826495
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of RXR-DNA interactions.
Zhao Q; Chasse SA; Devarakonda S; Sierk ML; Ahvazi B; Rastinejad F
J Mol Biol; 2000 Feb; 296(2):509-20. PubMed ID: 10669605
[TBL] [Abstract][Full Text] [Related]
3. Millisecond to microsecond time scale dynamics of the retinoid X and retinoic acid receptor DNA-binding domains and dimeric complex formation.
van Tilborg PJ; Mulder FA; de Backer MM; Nair M; van Heerde EC; Folkers G; van der Saag PT; Karimi-Nejad Y; Boelens R; Kaptein R
Biochemistry; 1999 Feb; 38(7):1951-6. PubMed ID: 10026278
[TBL] [Abstract][Full Text] [Related]
4. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor-DNA interactions.
Shaffer PL; Gewirth DT
Vitam Horm; 2004; 68():257-73. PubMed ID: 15193458
[TBL] [Abstract][Full Text] [Related]
6. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
7. Ligand- and DNA-induced dissociation of RXR tetramers.
Chen ZP; Iyer J; Bourguet W; Held P; Mioskowski C; Lebeau L; Noy N; Chambon P; Gronemeyer H
J Mol Biol; 1998 Jan; 275(1):55-65. PubMed ID: 9451439
[TBL] [Abstract][Full Text] [Related]
8. High-resolution solution structure of the retinoid X receptor DNA-binding domain.
Holmbeck SM; Foster MP; Casimiro DR; Sem DS; Dyson HJ; Wright PE
J Mol Biol; 1998 Aug; 281(2):271-84. PubMed ID: 9698548
[TBL] [Abstract][Full Text] [Related]
9. Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors.
Wu Y; Yang YZ; Koenig RJ
Mol Endocrinol; 1998 Oct; 12(10):1542-50. PubMed ID: 9773977
[TBL] [Abstract][Full Text] [Related]
10. Conformational dynamics and molecular recognition: backbone dynamics of the estrogen receptor DNA-binding domain.
Wikström A; Berglund H; Hambraeus C; van den Berg S; Härd T
J Mol Biol; 1999 Jun; 289(4):963-79. PubMed ID: 10369775
[TBL] [Abstract][Full Text] [Related]
11. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding.
Figueira AC; Dias SM; Santos MA; Apriletti JW; Baxter JD; Webb P; Neves FA; Simeoni LA; Ribeiro RC; Polikarpov I
Cell Biochem Biophys; 2006; 44(3):453-62. PubMed ID: 16679533
[TBL] [Abstract][Full Text] [Related]
12. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
Germain P; Iyer J; Zechel C; Gronemeyer H
Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
[TBL] [Abstract][Full Text] [Related]
13. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors.
Perlmann T; Umesono K; Rangarajan PN; Forman BM; Evans RM
Mol Endocrinol; 1996 Aug; 10(8):958-66. PubMed ID: 8843412
[TBL] [Abstract][Full Text] [Related]
14. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
Quack M; Carlberg C
J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
[TBL] [Abstract][Full Text] [Related]
15. RAR antagonists diminish the level of DNA binding by the RAR/RXR heterodimer.
Poujol N; Margeat E; Baud S; Royer CA
Biochemistry; 2003 May; 42(17):4918-25. PubMed ID: 12718533
[TBL] [Abstract][Full Text] [Related]
16. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
19. Changes in dynamical behavior of the retinoid X receptor DNA-binding domain upon binding to a 14 base-pair DNA half site.
van Tilborg PJ; Czisch M; Mulder FA; Folkers GE; Bonvin AM; Nair M; Boelens R; Kaptein R
Biochemistry; 2000 Aug; 39(30):8747-57. PubMed ID: 10913286
[TBL] [Abstract][Full Text] [Related]
20. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
